Sihuan Pharmaceutical Holdings Group Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sihuan Pharmaceutical Holdings Group Ltd with three other
companies in this sector in China:
Anhui Fengyuan Pharmaceutical
sales of 2.98 billion Chinese Renmimbi [US$430.48 million]
Chengdu Kanghong Pharmaceutical Group Co Ltd
(2.92 billion Chinese Renmimbi [US$422.09 million]
of which 100%
was Pharmaceutical Manufacturing), and
Jinling Pharmaceutical Company Limited
(2.90 billion Chinese Renmimbi [US$419.44 million]
of which 60%
was Medicine Manufacture).
During the year ended December of 2018, sales at
Sihuan Pharmaceutical Holdings Group Ltd were 2.92 billion Chinese Renmimbi (US$422.09 million).
increase of 6.2%
versus 2017, when the company's sales were 2.75 billion Chinese Renmimbi.
Despite this increase, sales are still
below the level achieved in 2016, when Sihuan Pharmaceutical Holdings Group Ltd
reported sales of 3.19 billion Chinese Renmimbi.